Comparison of 1% Versus 2% Lignocaine for Topical Anaesthesia in Endobronchial Ultrasound Guided Transbronchial Needle Aspiration
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Operator rated cough VAS
研究概览
简要总结
Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS -TBNA) is commonly performed for diagnosis of mediastinal pathologies. The procedure can either be performed under general anaesthesia or under moderate sedation with topical anaesthesia. Most patients tolerate the procedure well although cough is often reported as a distressing symptom. Topical lignocaine is administered during bronchoscopy for local anaesthesia. There is no literature on the efficacy of lower concentrations (1%) versus a higher (2%) during EBUS TBNA. This study would help to determine whether 1% lignocaine is as effective as 2% lignocaine for airway anaesthesia during EBUS-TBNA.
详细描述
For all patients meeting the inclusion criteria, the demographic profile including age, sex, weight, smoking history shall be recorded. A written informed consent will be obtained from all participants. The patients who undergo EBUS-TBNA under moderate sedation would be randomised in a one is to one ratio either to 1% lignocaine or 2% lignocaine group. Prior to EBUS-TBNA, Blood pressure, pulse rate, respiratory rate and pulse oximetry saturation will be recorded at the baseline Patients in both the groups shall be prepared in a similar fashion except for the concentration of lignocaine used. Two different concentration of lignocaine solution will be labelled as solution 'A' or solution 'B' containing either of 1% or 2% lignocaine solution .Operator will be provided either solution A or B based on the initial randomisation.
During the procedure, 1.5ml aliquots of the provided lignocaine solution will be delivered through the bronchoscope using spray-as-you go technique. The total number of aliquots used during the procedure will be recorded. The patients would be monitored for any adverse effects throughout the procedure. The bronchoscopist doing the procedure will be provided 2 VAS charts to mark the severity of cough and overall procedure satisfaction.
Post procedure, patients will record the pain experienced while undergoing the procedure on the faces pain rating scale.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Indication for diagnostic or therapeutic flexible bronchoscopy
- •Age > 18 years
排除标准
- •Refusal of consent
- •Known documented hypersensitivity to lignocaine
- •Procedure performed under general anaesthesia
- •Pregnancy
- •Hypoxemia (oxygen saturation [by pulse oximetry] < 92% with Fio2 of ≥ 0.3
研究组 & 干预措施
1 % Lignocaine
1 % Lignocaine administered for topical anaesthesia during EBUS-TBNA
干预措施: Lignocaine 1% concentration solution (Drug)
2 % Lignocaine
2 % Lignocaine administered for topical anaesthesia during EBUS-TBNA
干预措施: Lignocaine 2% concentration solution (Drug)
结局指标
主要结局
Operator rated cough VAS
时间窗: At study completion approximately 6 months
Operator rated overall procedure satisfaction VAS
时间窗: At study completion approximately 6 months
次要结局
- Total lignocaine dose administered(At study completion approximately 6 months)
- Patient facies pain rating scale(At study completion approximately 6 months)
- Procedure related adverse events(At study completion approximately 6 months)
研究者
Karan Madan
Dr. Karan Madan, MD, DM Assistant Professor, Pulmonary Medicine and Sleep Disorders
All India Institute of Medical Sciences, New Delhi